CoChat

Use of a drug‐resistant mutant of stress‐activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580

Open access
Eyers, Patrick A., van den IJssel, Paul, Quinlan, Roy A., Goedert, Michel, Cohen, Philip · 1999 · FEBS Letters
Cited by 113

The DOI matches its Crossref record.

Abstract

Stress‐activated protein kinase 2a, also called p38, is inhibited by SB 203580 and this drug has been used widely to implicate this enzyme in the regulation of many physiological processes. Here, we introduce a novel method of general application, which can be used to establish whether the effects of SB 203580 are mediated via inhibition of stress‐activated protein kinase 2a/p38 or whether they result from ‘non‐specific’ effects. Four events thought to occur upon activation of stress‐activated protein kinase 2a/p38 have been established unequivocally. These are the activation of mitogen‐activated protein kinase‐activated protein kinase‐2 and mitogen‐ and stress‐activated protein kinase‐1 and the phosphorylation of their presumed substrates, heat shock protein 27 and the transcription factor cyclic AMP response element binding protein, respectively. In contrast, the SB 203580‐induced activation of c‐Raf is independent of stress‐activated protein kinase 2a/p38 inhibition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0014-5793(99)00552-9

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 113

Metadata

Authors
Eyers, P. A., van den IJssel, P., Quinlan, R. A., Goedert, M., & Cohen, P.
Venue
FEBS Letters
Publisher
Wiley
Published
1999-05-21
Volume
451
Issue
2
Pages
191-196
ISSN
  • 0014-5793 (ISSN-L)
  • 1873-3468
OpenAlex
W2067381705
Cited by
113
References
0
FWCI
3.37
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of a drug‐resistant mutant of stress‐activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580. https://app.cochat.ai/papers/10.1016/s0014-5793(99)00552-9
The paper
Eyers, P. A., van den IJssel, P., Quinlan, R. A., Goedert, M., & Cohen, P. (1999). Use of a drug‐resistant mutant of stress‐activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580. FEBS Letters. https://doi.org/10.1016/s0014-5793(99)00552-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.